Erica Warlick, MD

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation

Erica Warlick

Contact Info

Mailing Address:
Division of Hematology, Oncology and Transplantation
420 Delaware Street SE
MMC 480
Minneapolis, MN 55455

Administrative Assistant Name
Bickie Pham

Administrative Phone
612-625-8287

Administrative Email
pham0179@umn.edu

Administrative Fax Number
612-625-6919

Associate Professor of Medicine, Division of Hematology, Oncology and Transplantation


Hematologist / Oncologist


Medical School, University of Minnesota, Minneapolis, MN

Internal Medicine Residency, Johns Hopkins University, Baltimore MD

Oncology Fellowship, Johns Hopkins University, Baltimore, MD

Summary

Dr. Warlick received her M.D. from the University of Minnesota in 2001 and completed her Internal Medicine residency and fellowships in Medical Oncology and Hematology at Johns Hopkins University in 2007. Dr. Warlick is Medical Director of the Adult Blood and Marrow Transplant Clinic.

Awards & Recognition

  • Champion of Care, Fairview: Patient Recognition (2012)

Professional Associations

  • Alpha Omega Alpha

Research

Research Summary/Interests

Dr. Warlick’s clinical and research efforts focus on the treatment of hematologic malignancies. She has particular interest in myeloid malignancies and the development of new strategies utilizing hematopoietic stem cell transplantation, traditional chemotherapeutics, as well as novel biologic modifiers to treat this diverse group of diseases.

Publications

  • Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients.
    Pease DF, Ross JA, Poynter JN, Nguyen PL, Hirsch B, Cioc A, Roesler MA, Warlick ED.
    Cancer Epidemiol. 2015 Apr;39(2):222-8. doi: 10.1016/j.canep.2015.01.006. Epub 2015 Feb 18.
  • Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR.
  • Ustun C, Trottier BJ, Sachs Z, DeFor TE, Shune L, Courville E, Holtan SG, Dolan M, Weisdorf DJ, Warlick ED. Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome. Biol Blood Marrow Transplant. 2015 Jan 22 [Epub ahead of print]
  • Warlick ED, Peffault de Latour R, Shanley R, Robin M, Bejanyan N, Xhaard A, Brunstein C, Sicre de Fontbrune F, Ustun C, Weisdorf DF, Socie G. Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type. Biol Blood Marrow Transplant. 2015 Feb;21(2):357-63.
  • Bejanyan N, Oran B, Shanley R, Warlick E, Ustun C, Vercellotti G, Verneris M, Wagner JE, Weisdorf D, Brunstein C. Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation. Bone Marrow Transplant. 2014 Aug;49(8):1029-35.
  • Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients.
    Pease DF, Ross JA, Poynter JN, Nguyen PL, Hirsch B, Cioc A, Roesler MA, Warlick ED.
    Cancer Epidemiol. 2015 Apr;39(2):222-8. doi: 10.1016/j.canep.2015.01.006. Epub 2015 Feb 18.
  • Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.
    Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR.

Clinical

Clinics

Blood and Marrow Transplant (BMT) Clinic;Masonic Cancer Center

Board Certifications

  • Internal Medicine
  • Oncology
  • Hematology

Clinical Interests

Myelodysplastic syndromes; Leukemia (AML, CML, CLL); Lymphoma; Multiple myeloma